PRESS RELEASE published on 05/08/2024 at 08:30, 1 year 6 months ago Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024 Abivax annonce la présentation de quatre abstracts sur obefazimod dans la rectocolite hémorragique et dans un modèle préclinique de cancer du côlon lors du congrès Digestive Disease Week 2024 Abivax Obefazimod Rectocolite Hémorragique Cancer Du Côlon Digestive Disease Week 2024
PRESS RELEASE published on 05/08/2024 at 08:30, 1 year 6 months ago Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF published on 05/07/2024 at 22:05, 1 year 6 months ago Abivax Announces Availability of Documents for Upcoming General Meeting Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
BRIEF published on 05/07/2024 at 22:05, 1 year 6 months ago Abivax annonce la mise à disposition des documents pour la prochaine assemblée générale Biotechnologie Abivax Assemblée Générale Gouvernance D'Entreprise Informations Pour Les Actionnaires
PRESS RELEASE published on 05/07/2024 at 22:01, 1 year 6 months ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires Abivax annonce la tenue de son assemblée générale annuelle et extraordinaire le 30 mai 2024 à Paris. Mise à disposition des documents préparatoires pour les actionnaires Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires
PRESS RELEASE published on 05/07/2024 at 22:00, 1 year 6 months ago Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE published on 05/07/2024 at 22:00, 1 year 6 months ago Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website Shareholders Biotechnology Abivax General Meeting Preparatory Documents
PRESS RELEASE published on 05/07/2024 at 22:00, 1 year 6 months ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires
BRIEF published on 04/30/2024 at 18:05, 1 year 7 months ago ABIVAX rapporte le nombre d'actions et de droits de vote au 31 mars 2024 Autorité Des Marchés Financiers Droits De Vote Capital Social Abivax Informations Réglementaires
BRIEF published on 04/30/2024 at 18:05, 1 year 7 months ago ABIVAX reports the number of shares and voting rights as of March 31, 2024 Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
Published on 12/07/2025 at 09:00, 1 hour 52 minutes ago Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Published on 12/06/2025 at 20:10, 14 hours 42 minutes ago New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth
Published on 12/06/2025 at 02:00, 1 day 8 hours ago Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 1 day 9 hours ago Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 1 day 10 hours ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 18:08, 16 hours 44 minutes ago EQS-Adhoc: Klöckner & Co SE: Klöckner & Co SE confirms rumors on negotiations regarding a potential voluntary public takeover offer by Worthington Steel, Inc.
Published on 12/06/2025 at 17:50, 17 hours 2 minutes ago Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit
Published on 12/06/2025 at 16:45, 18 hours 7 minutes ago Blokees exhibits at CCXP25 in Brazil: World Premiere of the New Saint Seiya Product
Published on 12/06/2025 at 16:30, 18 hours 22 minutes ago Döhler Opens New R&D Centre in Shanghai to Accelerate Innovation across Asia-Pacific
Published on 12/05/2025 at 22:15, 1 day 12 hours ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/06/2025 at 13:26, 21 hours 26 minutes ago Total number of voting rights and shares making up the share capital at November30, 2025
Published on 12/06/2025 at 13:26, 21 hours 26 minutes ago Capital et droits de vote au 30 novembre 2025
Published on 12/05/2025 at 23:00, 1 day 11 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 day 11 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 day 11 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025